Predictors of pain response in patients undergoing endoscopic ultrasound-guided neurolysis for abdominal pain caused by pancreatic cancer

Conclusions:
EUS-BPN in combination with EUS-CGN was a predictor of a good pain response in EUS-guided neurolysis for pancreatic cancer-related pain. The larger number of neurolytic/contrast spread areas may lead to better outcomes in patients receiving combination treatment.

Source: Therapeutic Advances in Gastroenterology - June 11, 2016 Category: Gastroenterology Authors: Minaga, K., Kitano, M., Sakamoto, H., Miyata, T., Imai, H., Yamao, K., Kamata, K., Omoto, S., Kadosaka, K., Sakurai, T., Nishida, N., Chiba, Y., Kudo, M. Tags: Original Research Source Type: research